With new brand identity, SAB BIO continues drive towards serious unmet needs in type 1 diabetes MIAMI, June 20, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (SABS) (the “Company” or “SAB”), a clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results